BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37808628)

  • 1. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
    Hendrickson PG; Oristian KM; Browne MR; Lou L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
    Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
    Res Sq; 2023 Oct; ():. PubMed ID: 37961185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.
    Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Nash JO; Ballester PL; Davidson S; Shlien A; Linardic CM; Kirsch DG
    Oncogene; 2024 Apr; 43(16):1223-1230. PubMed ID: 38413794
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yoshimoto T; Tanaka M; Homme M; Yamazaki Y; Takazawa Y; Antonescu CR; Nakamura T
    Cancer Res; 2017 Jun; 77(11):2927-2937. PubMed ID: 28404587
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.
    Bosnakovski D; Ener ET; Cooper MS; Gearhart MD; Knights KA; Xu NC; Palumbo CA; Toso EA; Marsh GP; Maple HJ; Kyba M
    Oncogenesis; 2021 Oct; 10(10):68. PubMed ID: 34642317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma.
    Thomas NJ; Luck C; Shlimon N; Ponce RK; Kosibaty Z; Okimoto RA
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
    Bakaric A; Cironi L; Praz V; Sanalkumar R; Broye LC; Favre-Bulle K; Letovanec I; Digklia A; Renella R; Stamenkovic I; Ott CJ; Nakamura T; Antonescu CR; Rivera MN; Riggi N
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
    Rekhi B; Rumdee R; Shetty O
    Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
    Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
    J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
    Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
    Carrabotta M; Laginestra MA; Durante G; Mancarella C; Landuzzi L; Parra A; Ruzzi F; Toracchio L; De Feo A; Giusti V; Pasello M; Righi A; Lollini PL; Palmerini E; Donati DM; Manara MC; Scotlandi K
    Cancer Res; 2022 Feb; 82(4):708-720. PubMed ID: 34903601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion.
    Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
    Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
    Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
    Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
    Chebib I; Jo VY
    Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the
    Rekhi B; Kembhavi P; Mishra SN; Shetty O; Bajpai J; Puri A
    Indian J Med Res; 2019 Dec; 150(6):557-574. PubMed ID: 32048619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association.
    Tardío JC; Machado I; Navarro L; Idrovo F; Sanz-Ortega J; Pellín A; Llombart-Bosch A
    Pathol Res Pract; 2015 Nov; 211(11):877-82. PubMed ID: 26386605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.
    Graham C; Chilton-MacNeill S; Zielenska M; Somers GR
    Hum Pathol; 2012 Feb; 43(2):180-9. PubMed ID: 21813156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.
    Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM
    Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
    Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
    Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.